Skip to content
10-Q

Quarterly Report

Coeptis Therapeutics, Inc.

0001683168-21-003708

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 16, 2021 34.15M sh
Long Term Debt Q2 2021 · Jun 30, 2021 $150K
Long Term Debt Q2 2021 · Dec 31, 2020 $150K
Current Liabilities Q2 2021 · Jun 30, 2021 $4.71M
Current Liabilities Q2 2021 · Dec 31, 2020 $5.28M
Total Liabilities Q2 2021 · Jun 30, 2021 $4.88M
Total Liabilities Q2 2021 · Dec 31, 2020 $5.44M
Current Assets Q2 2021 · Jun 30, 2021 $1.93M
Current Assets Q2 2021 · Dec 31, 2020 $224.75K
Total Assets Q2 2021 · Jun 30, 2021 $2.74M
Total Assets Q2 2021 · Dec 31, 2020 $300.48K
Rd Expense Q2 2021 · Jun 30, 2021 $0
Rd Expense Q2 2021 · Jun 30, 2021 $0
Rd Expense Q2 2021 · Jun 30, 2020 $3.54K
Rd Expense Q2 2021 · Jun 30, 2020 $3.54K
Net Income Q2 2021 · Mar 31, 2021 −$1.95M
Net Income Q2 2021 · Jun 30, 2020 −$685.25K
Net Income Q2 2021 · Jun 30, 2020 −$2.57M
Net Income Q2 2021 · Mar 31, 2020 −$1.9M
Capex Q2 2021 · Jun 30, 2020 $0
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$1.64M
Stockholders Equity Q2 2021 · Jun 30, 2020 −$1.92M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$1.57M
Stockholders Equity Q2 2021 · Dec 31, 2019 $621.53K
Sga Expense Q2 2021 · Jun 30, 2020 $661.86K
Sga Expense Q2 2021 · Jun 30, 2020 $1M
Operating Income Q2 2021 · Jun 30, 2020 −$687.24K
Operating Income Q2 2021 · Jun 30, 2020 −$1.07M
Gross Profit Q2 2021 · Jun 30, 2020 $14.5K
Gross Profit Q2 2021 · Jun 30, 2020 $19K
Cost Of Revenue Q2 2021 · Jun 30, 2020 $1.87K
Cost Of Revenue Q2 2021 · Jun 30, 2020 $1.87K
Revenue Q2 2021 · Jun 30, 2020 $16.37K
Revenue Q2 2021 · Jun 30, 2020 $20.87K